PACES Trial S0820 – CRC CLINICAL TRIAL UPDATE

Since the inception of Fight Colorectal Cancer (Fight CRC), we have advocated for and supported cancer research. Today kicks off the first off many blogs where I will update you on the latest clinical trials for colorectal cancer research. Learn the process of clinical trials. NCI’s Colon Task Force First – some background. Nancy Roach, our founder…  Read More

Ramucirumab – A New Treatment Option

The FDA approved the use of the drug ramucirumab (brand name Cyramza®) on April 24, 2015 for patients with metastatic colorectal cancer in combination with FOLFIRI. Ramucirumab with FOLFIRI is now approved for patients whose cancer has progressed during or after treatment with first line therapies (typically FOLFOX and bevacizumab (Avastin®). Ramucirumab was approved after the…  Read More

Ramucirumab Treatment

There’s news coming out of a recent clinical trial evaluating the chemotherapy drug ramucirumab (Cyramza™) and colorectal cancer patients’ response. Read more to learn about this update in treatment. Breaking research for mCRC patients Recently Eli Lilly and Company announced that the RAISE trial showed a statistically significant improvement for patients treated with ramucirumab (Cyramza™). This…  Read More

Another treatment option coming down the pike: TAS-102

Fight Colorectal Cancer stays actively involved in the research process from beginning to end. Part of our role in research is monitoring the progress of new drugs – drugs that may be used in treatment plans of colorectal cancer in the future. We actively work with drug companies to stay up-to-date on the latest treatments so…  Read More

Meet the One Million Strong – Diana Welch from Maryland

Be a part of One Million Strong and tell us how colorectal cancer has impacted your life! Share your story now!  MEET DIANA Diana Welch, Survivor Huntingtown, MD DIANA’S STORY After several months of severe upper abdominal pain and learning to be my own advocate, I was diagnosed with stage IV colon cancer in March 2012.  …  Read More

Fight Colorectal Cancer, National Cancer Institute recruit colon cancer survivors

FOR IMMEDIATE RELEASE Aug. 2, 2013 – ALEXANDRIA, Va. — Fight Colorectal Cancer is working with The National Cancer Institute (NCI) to recruit participants for a new study testing informed consent documentation. Study participants will evaluate an informed consent document (ICD) that explains a clinical trial and determine its clarity and ease of use. Participants will be paid $40 for…  Read More